Previous studies have shown that silencing eIF3a is effective in suppressing cell proliferation and EMT in thyroid,13 liver,16 and pancreatic cancer.15 The present results support a role for eIF3a as an oncogene in CRC. This evidence concerns the gene EIF3A and colorectal carcinoma.